Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 10, 2017

Primary Completion Date

May 30, 2019

Study Completion Date

June 30, 2019

Conditions
AsthmaPediatric ALL
Interventions
DRUG

budesonide, beclomethasone

The inhaled corticosteroids we are using for this study are budesonide nebulized solution and beclomethasone metered-dose inhaler. Low-doses for these medications are 0.5mg/day for budesonide and 160 mcg/day for beclomethasone. Patients under 5 years of age will receive low dose budesonide solution 0.25mg/respule to be given twice a day via nebulizer. Budesonide is FDA approved for children under 5 years of age. Patients 5 years and older will receive one beclomethasone metered-dose inhaler (MDI) 40mcg/puff two puffs twice a day via spacer. Beclomethasone is FDA approved for children 5 years and older.

Trial Locations (1)

11203

Kings County Hospital Center, Brooklyn

All Listed Sponsors
lead

New York City Health and Hospitals Corporation

OTHER

NCT03369847 - Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge | Biotech Hunter | Biotech Hunter